Construction and characterization of a potential live oral carrier- based vaccine against Vibrio cholerae O139

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3565-3570

  Favre, Didier ^a   Cryz Jr , Stanley J ^a   Virex, Jean François ^a  

^a Berna Biotech AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE;

ANTIBODY TITER; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CELL MOTILITY; COSMID; GENE INSERTION; GENE LOCUS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SCREENING TEST; SEROTYPE; VACCINATION; VIBRIO CHOLERAE;

EID: 0029756751     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3565-3570.1996     Document Type: Article

References (47)

1. Albert, M. J. 1994. Vibrio choleras O139 Bengal. J. Clin. Microbiol. 32:2345-2349.
2. Bastin, D. A., L. K. Romana, and P. R. Reeves. 1991. Molecular cloning and expression in Escherichia coli K-12 of the rfb gene cluster determining the O antigen of an E. coli O111 strain. Mol. Microbiol. 5:2223-2231.
3. Batchelor, R. A., P. Alifano, E. Biffali, S. I. Hull, and R. A. Hull. 1992 Nucleotide sequences of Ehe genes regulating O-polysaccharide antigen chain length (rol) from Escherichia coli and Salmonella typhimurium: protein homology and functional complementation. J. Bacteriol. 174:5228-5236.
4. Berche, P., C. Poyart, E. Abachin, H. Lelievre, J. Vandepilte, A. Dodin, and J.-M. Fournier. 1994. The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio chokrae. J. Infect. Dis. 170:701-704.
5. Bhadra, R. K., S. Roychoudury, R. K. Banerjee, S. Kar, R. Majumdar, S. Sengupta, S. Chatterjee, G. Khetawal, and J. Das. 1995. Cholera toxin (CTX) genetic element in Vibrio cholerae O139. Microbiology 141:1977-1983.
6. Bik, E. M., A. E. Bunschoten, R. D. Gouw, and F. R. Mooi. 1995. Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J. 14:209-216.
7. Bruderer, U., E. Fürer, S. J. Cryz, Jr., and A. B. Lang. 1990. Qualitative analysis of antibody binding. An in vitro assay for the evaluation and development of vaccines. J. Immunol. Methods 133:263-268.
8. Calia, K. E., M. Murtagh, M. J. Ferraro, and S. B. Calderwood. 1994. Comparison of Vibrio cholerae O139 with K cholerae O1 classical and El Tor biotypes. Infect. Immun. 62:1504-1506.
9. Comstock, L. E., J. A. Johnson, J. A. Michalski, J. G. Morris, and J. B. Kaper. 1996. Cloning and sequence of a region encoding a surface polysac- charide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol. Microbiol. 19:815-826.
10. Comstock, L. E., D. Maneval, Jr., P. Panigrahi, A. Joseph, M. M. Levine, J. B. Kaper, J. G. Morris, Jr., and J. A. Johnson. 1995. The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect. Immun. 63:317-323.
11. Coster, T. S., K. P. Killeen, M. K. Waldor, D. T. Beattie, D. R. Spriggs, J. R. Kenner, A. Trofa, J. C. Sadoff, J. J. Mekalanos, and D. N. Taylur. 1995. Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet 345:949-952.
12. inaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O-polysaccharide. Infect. Immun. 64:576-584.
13. Favre, D., M. M. Struck, S. J. Cryz, Jr., and J.-F. Viret. 1996. Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgR. Vaccine 14:526-531.
14. 13a. Favre, D., and J.-F. Viret. Versatile cosmid vectors for facilitated analysis and subcloning of the insert. Gene, in press.
15. Hall, R. H., F. M. Khambaty, M. H. Kothari, S. P. Keasler, and B. T. Tall. 1994. Vibrio cholerae non-O1 serogroup associated with cholera gravis genetically and physiologically resembles Ol El Tor cholera strains. Infect. Immun. 62:3859-3863.
16. Janda, J. M., C. Powers, R. G. Bryant, and S. L. Abbott. 1988. Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp. Clin. Microbiol. Rev. 1:245-267.
17. Johnson, J. A., C. A. Salles, P. Panigrahi, M. J. Albert, A. C. Wright, R. J. Johnson, and J. G. Morris, Jr. 1994. Vibrio cholerae O139 synonym Bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect. Immun. 62:2108-2110.
18. Karaolis, D. K. R., R. Lan, and P. R. Reeves. 1994. Molecular evolution of the seventh-pandemic clone of Vibrio cholerae and its relationship to other pandemic and epidemic V. cholerae isolates. J. Bacteriol. 176:6199-6206.
19. Karaolis, D. K. R., R. Lan, and P. R. Reeves. 1995. The sixth and seventh cholera pandemics are due to independent clones separately derived from environmental, nontoxigenic, non-O1 Vibrio cholerae. J. Bacteriol. 177:3191-3198.
20. Keen, N. T., S. Tamaki, D. Kobayashi, and D. Trollinger. 1988. Improved broad-host-range plasmids for DNA cloning in Gram-negative bacteria. Gene 70:191-197.
21. Kelley, J. M., J. Michalski, J. Galen, M. M. Levine, and J. B. Kaper. 1993. Construction of genetically marked Vibrio cholerae O1 vaccine strains. FEMS Microbiol. Lett. 111:15-22.
22. Knirel, Y. A., L. Paredes, P.-E. Jansson, A. Weintraub, G. Widmalm, and M. J. Albert. 1995. Structure of the capsular polysaccharide of Vibrio cholerae O139 synonym Bengal containing D-galactose 4,6-cyclophosphate. Eur. J. Biochem. 232:391-396.
23. Levine, M. M., J. B. Kaper, D. A. Herrington, G. A. Iosonsky, J. G. Morris, M. L. Clements, R. E. Black, B. D. Tall, and R. Hall. 1988. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect. Immun. 56:161-167.
24. Macpherson, D. F., R. Morona, D. W. Beger, K.-C. Cheah, and P. A. Manning. 1991. Genetic analysis of the rfb region of Shigella fiexneri encoding the Y serotype O-antigen specificity. Mol. Microbiol. 5:1491-1499.
25. Mandal, B. K. 1993. Epidemic cholera due to a novel strain of V. cholerae non-O1-the beginning of a new pandemic? J. Infect. 27:115-117.
26. Marcus, H., J. M. Ketley, J. B. Kaper, and R. K. Holmes. 1990. Effects of DNase production, plasmid size, and restriction barriers on transformation of Vibrio cholerae by electroporation and osmotic shock. FEMS Microbiol. Lett. 68:149-154.
27. Mitra, S. N., S. Kar, R. K. Ghosh, S. Pajni, and A. Ghosh. 1995. Presence of lysogenic phage in the outbreak strains of Vibrio cholerae O139. J. Med. Microbiol. 42:399-403.
28. Morona, R., L. Van den Bosch, and P. A. Manning. 1995. Molecular, genetic, and topological characterization of O-antigen chain length regulation in Shigella flexneri. J. Bacteriol. 177:1059-1068.
29. Morris, J. G., Jr. 1995. Vibrio cholerae O139 Bengal: emergence of a new epidemic strain of cholera. Infect. Agents Dis. 4:41-46.
30. Morris, J. G., G. E. Losonsky, J. A. Johnson, C. O. Tacket, J. P. Nataro, P. Panigrahi, and M. M. Levine. 1995. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J. Infect. Dis. 171:903-908.
31. Pajni, S., N. R. Chowdhury, A. Ghosh, S. Kar, and R. K. Ghosh. 1995 Characterization of phage φ O139, a Vibrio cholerae O139 temperate bacteriophage with cohesive DNA termini. FEMS Microbiol. Lett. 131:69-74.
32. Ramamurthy, T., S. Garg, R. Sharma, S. K. Bhattacharya, G. B. Nair, T. Shimada, T. Takeda, T. Karasawa, H. Kurazono, A. Pal, and Y. Takada. 1993. Emergence of a novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 341:703-704.
33. Sack, D. A., and R. B. Sack. 1975. Test for enterotoxigenic Escherichia coli using Y1 adrenal cells in miniculture. Infect. Immun. 11:334-336.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
35. Simon, R., U. Priefer, and A. Pünier. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Bio/Technology 1:784-791.
36. Strocher, U. H., K. E. Jedani, B. K. Dredge, R. Morona, M. H. Brown, L. E. Karageorgos, M. J. Albert, and P. A. Manning. 1995. Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139. Proc. Natl. Acad. Sci. USA 92:10374-10378.
37. Svennerholm, A.-M., and J. Holmgren. 1978. Identification of Escherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GM1-ELISA) procedure. Curr. Microbiol. 1:19-23.
38. Swerdlow, D. L., and A. A. Ries. 1993. Vibrio cholerae non-O1-the eighth pandemic? Lancet 342:382-383.
39. Tacket, C. O., G. Losonsky, J. P. Nataro, L. Comstock, J. Michalski, R. Edelman, J. B. Kaper, and M. M. Levine. 1995. Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J. Infect. Dis. 172:883-886.
40. Tacket, C. O., G. Losonsky, J. P. Nataro, S. J. Cryz, R. Edelman, A. Fasano, J. Michalski, J. B. Kaper, and M. M. Levine. 1993. Safety, immunogenicity, and transmissibility of live oral cholera vaccine candidate CVD110, a Δctx, Δzot, Aace derivative of El Tor Ogawa Vibrio cholerae. J. Infect. Dis. 168:1536-1540.
41. Takeda, T., T. Ramamurthy, A. S. Chowdhury, D. Dutta, S. K. Bhattacharya, B. C. Deb, G. B. Nair, and Y. Takeda. 1994. Vibrio cholerae O1 vibriocidal and anti-cholera toxin antibodies in 0139 Bengal cholera patients. J. Infect. 29:233-235.
42. Viret, J.-F., S. J. Cryz, and D. Favre. 1996. Expression of Shigella sonnei lipopolysaccharide in Vibrio cholerae. Mol. Microbiol. 19:949-963.
43. Waldor, M. K., R. Colwell, and J. J. Mekalanos. 1994. The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and polysaccharide virulence determinants. Proc. Natl. Acad. Sci. USA 91:11388-11392.
44. Waldor, M. K., and J. J. Mekalanos. 1994. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. J. Infect. Dis. 170:278-283.
45. Weintraub, A., G. Widmalm, P.-E. Jansson, M. Jansson, K. Hultenby, and M. J. Albert. 1994. Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence. Microb. Pathog. 16:235-241.
46. Wilkinson, R. G., P. Gemski, Jr., and B. A. D. Stocker. 1972. Non-smooth mutants of Salmonella typhimurium: differentiation by phage sensitivity and genetic mapping. J. Gen. Microbiol. 70:527-554.
47. Yamamoto, T., G. B. Nair, and Y. Takeda. 1995. Emergence of tetracycline resistance due to a multiple drug resistance plasmid in Vibrio cholerae O139. FEMS Immunol. Med. Microbiol. 11:131-136.